Hyperinsulinaemia and iron perturbation in patients with type 2 diabetes

International Journal of Clinical Practice

Volumn 63, Issue 4, 2009, Pages 672-

  Mascitelli, L ^a   Pezzetta, F ^b   Goldstein, M R ^c  

^a Comando Brigata Alpina Julia ^*  (Italy)

^b Ospedale Civile di Tolmezzo   (Italy)

^c Fountain Medical Court ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; FERRITIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IRON; METFORMIN; SOMATOMEDIN C;

ARTICLE; EPIDEMIOLOGICAL DATA; FERRITIN BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; IRON ABSORPTION; IRON OVERLOAD; IRON STORAGE; LOW CARBOHYDRATE DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; IRON; MALE; METFORMIN; RISK FACTORS;

EID: 62549127713     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2008.01983.x     Document Type: Article

References (14)

1. Rajpathak SN, Crandall JP, Wylie-Rosett J, Kabat GC, Rohan TE, Hu FB. The role of iron in type 2 diabetes in humans. Biochim Biophys Acta 2008 Epub ahead of print] doi :.
2. Tuomainen TP, Nyyssonen K, Salonen R et al. Body iron stores are associated with serum insulin and blood glucose concentration: population study in 1,013 eastern Finnish men. Diabetes Care 1997 20 : 426 8.
3. Ford ES, Cogswell ME. Diabetes and serum ferritin concentration among U.S. adults. Diabetes Care 1999 22 : 1978 83.
4. Jiang R, Manson JE, Meigs JB, Ma J, Rifai N, Hu FB. Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA 2004 291 : 711 7.
5. Sun L, Franco OH, Hu FB et al. Ferritin concentrations, metabolic syndrome, and type 2 diabetes in middle-aged and elderly Chinese. J Clin Endocrinol Metab 2008 93 : 4690 6.
6. Facchini FS, Saylor KL. Effect of iron depletion on cardiovascular risk factors: studies in carbohydrate intolerant patients. Ann NY Acad Sci 2002 967 : 342 51.
7. Fernandez-Real JM, Penarroja G, Castro A, Garcia-Bragado F, Hernandez-Aguado I, Ricart W. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function. Diabetes 2002 51 : 1000 4.
8. Mascitelli L, Pezzetta F. Lowering body iron stores in the prevention of type 2 diabetes. Intern Med J 2006 36 : 685 6.
9. McCarty MF. Hyperinsulinemia may boost both hematocrit and iron absorption by upregulating activity of hypoxia-inducible factor-1alpha. Med Hypotheses 2003 61 : 567 73.
10. Susa JB, Schwartz R. Effects of hyperinsulinemia in the primate fetus. Diabetes 1985 34 (Suppl. 2 36 41.
11. Salvesen DR, Brudenell JM, Snijders RJ, Ireland RM, Nicolaides KH. Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus. Am J Obstet Gynecol 1993 168 : 88 94.
12. Niederau C, Berger M, Stremmel W et al. Hyperinsulinaemia in non-cirrhotic haemochromatosis: impaired hepatic insulin degradation? Diabetologia 1984 26 : 441 4.
13. Merkel PA, Simonson DC, Amiel SA et al. Insulin resistance and hyperinsulinemia in patients with thalassemia major treated by hypertransfusion. N Engl J Med 1988 318 : 809 14.
14. Luque-Ramírez M, Alvarez-Blasco F, Botella-Carretero JI et al. Increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism and are not a result of reduced menstrual losses. Diabetes Care 2007 30 : 2309 13.